Soleno Therapeutics filed an offering on July 10, 2025, with TD Cowen and Cantor as joint book-running managers, and the SEC (Bangladesh) was involved.
1 report, 1 independent
Updated Jul 10
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Soleno Therapeutics filed an offering on July 10, 2025, with TD Cowen and Cantor as joint book-running managers, and the SEC (Bangladesh) was involved.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
TD Cowen
American investment bank
- TD Cowen analysts are scrutinizing the business strategies of major financial institutions, including U.S. Bancorp and Wells Fargo, while Morgan Stanley also contributes to the inquiry.
- Multiple financial firms, including Morgan Stanley and TD Cowen, updated price targets and ratings for various institutions on October 31, 2026.
-
Cantor Fitzgerald
American financial services company
-
Soleno Therapeutics (United States)
company in Redwood City, United States
Nothing else this week.
Coverage
Newest first; wire copies grouped- GlobeNewswireSoleno Therapeutics Announces Pricing of $200 Million Public Offering of Common Stock REDWOOD CITY, Calif., July 10, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (Nasdaq: SLNO), a biop